Literature DB >> 8476637

Characterization and gene sequence of the precursor of elafin, an elastase-specific inhibitor in bronchial secretions.

J M Sallenave1, A Silva.   

Abstract

Human bronchial mucous secretions have been shown to contain inhibitors of serine proteinases secreted by neutrophils. The role of these inhibitors is probably to control the enzymes secreted in the airways and in the lung interstitium. Three of these inhibitors have been identified and characterized: alpha 1-proteinase inhibitor, mucus proteinase inhibitor, and elafin. The elafin molecule, a 6.0 kD inhibitor of serine proteinases shows homology with mucus proteinase inhibitor. We recently isolated both molecules in bronchial secretions. In this report, we present evidence for the existence of a precursor of the elafin molecule. We have cloned and sequenced the gene for this precursor and show that it is composed of three exons. The coding information for a 117 amino acid precursor protein of elafin (inclusive of the signal peptide) is contained in the first two exons. This was confirmed at the mRNA and protein levels. By Northern Blot analysis we detected a 800 bp long product, and by immunoaffinity we detected in sputum and in cultured epithelial cell supernatant (NCI-H322 cell line) a 12 kD protein species cross-reacting with anti-elafin IgG. The finding of possible cross-linking function for the precursor in addition to its antiproteinase activity indicates a possible role for this molecule as a cross-linker agent in the extracellular matrix.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8476637     DOI: 10.1165/ajrcmb/8.4.439

Source DB:  PubMed          Journal:  Am J Respir Cell Mol Biol        ISSN: 1044-1549            Impact factor:   6.914


  21 in total

1.  Inhibiting lung elastase activity enables lung growth in mechanically ventilated newborn mice.

Authors:  Anne Hilgendorff; Kakoli Parai; Robert Ertsey; Noopur Jain; Edwin F Navarro; Joanna L Peterson; Rasa Tamosiuniene; Mark R Nicolls; Barry C Starcher; Marlene Rabinovitch; Richard D Bland
Journal:  Am J Respir Crit Care Med       Date:  2011-09-01       Impact factor: 21.405

2.  Targeted overexpression of elafin protects mice against cardiac dysfunction and mortality following viral myocarditis.

Authors:  S H Zaidi; C C Hui; A Y Cheah; X M You; M Husain; M Rabinovitch
Journal:  J Clin Invest       Date:  1999-04       Impact factor: 14.808

3.  Functional characterization of polymorphisms in the peptidase inhibitor 3 (elafin) gene and validation of their contribution to risk of acute respiratory distress syndrome.

Authors:  Paula Tejera; D Shane O'Mahony; Caroline A Owen; Yongyue Wei; Zhaoxi Wang; Kushagra Gupta; Li Su; Jesus Villar; Mark Wurfel; David C Christiani
Journal:  Am J Respir Cell Mol Biol       Date:  2014-08       Impact factor: 6.914

Review 4.  The trappin gene family: proteins defined by an N-terminal transglutaminase substrate domain and a C-terminal four-disulphide core.

Authors:  J Schalkwijk; O Wiedow; S Hirose
Journal:  Biochem J       Date:  1999-06-15       Impact factor: 3.857

5.  Post-cardiac transplant arteriopathy in piglets is associated with fragmentation of elastin and increased activity of a serine elastase.

Authors:  S Oho; M Rabinovitch
Journal:  Am J Pathol       Date:  1994-07       Impact factor: 4.307

6.  Neonatal mice genetically modified to express the elastase inhibitor elafin are protected against the adverse effects of mechanical ventilation on lung growth.

Authors:  Anne Hilgendorff; Kakoli Parai; Robert Ertsey; G Juliana Rey-Parra; Bernard Thébaud; Rasa Tamosiuniene; Noopur Jain; Edwin F Navarro; Barry C Starcher; Mark R Nicolls; Marlene Rabinovitch; Richard D Bland
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2012-06-08       Impact factor: 5.464

7.  Elafin, a serine elastase inhibitor, attenuates post-cardiac transplant coronary arteriopathy and reduces myocardial necrosis in rabbits afer heterotopic cardiac transplantation.

Authors:  B Cowan; O Baron; J Crack; C Coulber; G J Wilson; M Rabinovitch
Journal:  J Clin Invest       Date:  1996-06-01       Impact factor: 14.808

8.  Antiproteases as therapeutics to target inflammation in cystic fibrosis.

Authors:  Derek J Quinn; Sinéad Weldon; Clifford C Taggart
Journal:  Open Respir Med J       Date:  2010-03-30

9.  Constitutive and inducible expression of SKALP/elafin provides anti-elastase defense in human epithelia.

Authors:  R Pfundt; F van Ruissen; I M van Vlijmen-Willems; H A Alkemade; P L Zeeuwen; P H Jap; H Dijkman; J Fransen; H Croes; P E van Erp; J Schalkwijk
Journal:  J Clin Invest       Date:  1996-09-15       Impact factor: 14.808

10.  Elafin Treatment Rescues EGFR-Klf4 Signaling and Lung Cell Survival in Ventilated Newborn Mice.

Authors:  Miguel A Alejandre Alcazar; Mark Kaschwich; Robert Ertsey; Stefanie Preuss; Carlos Milla; Sana Mujahid; Juliet Masumi; Suleman Khan; Lucia M Mokres; Lu Tian; Jasmine Mohr; Dharmesh V Hirani; Marlene Rabinovitch; Richard D Bland
Journal:  Am J Respir Cell Mol Biol       Date:  2018-11       Impact factor: 6.914

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.